Guangliang Chen
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 4
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid 3
- Rheumatology top 10%
- Hematology top 10%
-
- Lymphoma Diagnosis and Treatment 8
-
- CNS Lymphoma Diagnosis and Treatment 5
-
- Glioma Diagnosis and Treatment 5
-
- RNA modifications and cancer 4
-
- Salivary Gland Tumors Diagnosis and Treatment 3
-
- Ferroptosis and cancer prognosis 3
- Co-authors
- Georg SchettAline BözecTobias BäuerleLiangjing LuYubin LuoNatacha IpseizStefan WirtzGerhard Krönke
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Guangliang Chen
48 papers receiving 875 citations
Peers
Comparison fields: 5 of 119
- Cancer Research 179
- Nephrology 54
- Rheumatology 104
- Hematology 74
- Immunology 123
Countries citing papers authored by Guangliang Chen
This map shows the geographic impact of Guangliang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangliang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangliang Chen more than expected).
Fields of papers citing papers by Guangliang Chen
This network shows the impact of papers produced by Guangliang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangliang Chen. The network helps show where Guangliang Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guangliang Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 12 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 0 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 3 | |
| 13 | 2022 | 2 | |
| 14 | 2021 | 17 | |
| 15 | 2021 | 16 | |
| 16 | 2021 | 11 | |
| 17 | 2020 | 23 | |
| 18 | 2017 | 26 | |
| 19 | 2012 | 23 | |
| 20 | 2009 | 7 |
About Guangliang Chen
Guangliang Chen is a scholar working on Pathology and Forensic Medicine, Genetics and Cancer Research, having authored 53 papers that have together received 885 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (8 papers), CNS Lymphoma Diagnosis and Treatment (5 papers), Glioma Diagnosis and Treatment (5 papers), RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers), Salivary Gland Tumors Diagnosis and Treatment (3 papers), Gout, Hyperuricemia, Uric Acid (3 papers) and Ferroptosis and cancer prognosis (3 papers). The work is most often cited by research in Cancer Research (179 citations), Nephrology (54 citations) and Rheumatology (104 citations). Guangliang Chen has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Georg Schett, Aline Bözec, Tobias Bäuerle, Liangjing Lu, Yubin Luo, Natacha Ipseiz, Stefan Wirtz, Gerhard Krönke, Nicole Hannemann and Shuyun Xu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.